rx bridge limited
rx bridge limited Company Information
Company Number
09972799
Next Accounts
Dec 2025
Shareholders
woodsford tradebridge limited
Group Structure
View All
Industry
Other credit granting (not including credit granting by non-deposit taking finance houses and other specialist consumer credit grantors and activities of mortgage finance companies) n.e.c.
Registered Address
8 bloomsbury street, london, WC1B 3SR
rx bridge limited Estimated Valuation
Pomanda estimates the enterprise value of RX BRIDGE LIMITED at £19.1m based on a Turnover of £14.5m and 1.31x industry multiple (adjusted for size and gross margin).
rx bridge limited Estimated Valuation
Pomanda estimates the enterprise value of RX BRIDGE LIMITED at £11m based on an EBITDA of £2.3m and a 4.79x industry multiple (adjusted for size and gross margin).
rx bridge limited Estimated Valuation
Pomanda estimates the enterprise value of RX BRIDGE LIMITED at £8m based on Net Assets of £4.2m and 1.89x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Rx Bridge Limited Overview
Rx Bridge Limited is a live company located in london, WC1B 3SR with a Companies House number of 09972799. It operates in the other credit granting n.e.c. sector, SIC Code 64929. Founded in January 2016, it's largest shareholder is woodsford tradebridge limited with a 100% stake. Rx Bridge Limited is a young, mid sized company, Pomanda has estimated its turnover at £14.5m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Rx Bridge Limited Health Check
Pomanda's financial health check has awarded Rx Bridge Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 2 areas for improvement. Company Health Check FAQs
4 Strong
4 Regular
2 Weak
Size
annual sales of £14.5m, make it larger than the average company (£4.9m)
£14.5m - Rx Bridge Limited
£4.9m - Industry AVG
Growth
3 year (CAGR) sales growth of 104%, show it is growing at a faster rate (7.3%)
104% - Rx Bridge Limited
7.3% - Industry AVG
Production
with a gross margin of 35.6%, this company has a higher cost of product (59.1%)
35.6% - Rx Bridge Limited
59.1% - Industry AVG
Profitability
an operating margin of 15.8% make it as profitable than the average company (17.5%)
15.8% - Rx Bridge Limited
17.5% - Industry AVG
Employees
with 4 employees, this is similar to the industry average (5)
4 - Rx Bridge Limited
5 - Industry AVG
Pay Structure
on an average salary of £65.2k, the company has an equivalent pay structure (£65.2k)
- Rx Bridge Limited
£65.2k - Industry AVG
Efficiency
resulting in sales per employee of £3.6m, this is more efficient (£397.4k)
£3.6m - Rx Bridge Limited
£397.4k - Industry AVG
Debtor Days
it gets paid by customers after 246 days, this is near the average (246 days)
246 days - Rx Bridge Limited
246 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Rx Bridge Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Rx Bridge Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 1 weeks, this is less cash available to meet short term requirements (7 weeks)
1 weeks - Rx Bridge Limited
7 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 78.9%, this is a lower level of debt than the average (88.8%)
78.9% - Rx Bridge Limited
88.8% - Industry AVG
RX BRIDGE LIMITED financials
Rx Bridge Limited's latest turnover from March 2024 is £14.5 million and the company has net assets of £4.2 million. According to their latest financial statements, Rx Bridge Limited has 4 employees and maintains cash reserves of £371.8 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | |
|---|---|---|---|---|---|---|---|---|
| Turnover | 14,508,610 | 5,739,798 | 2,516,477 | 1,703,403 | 1,559,056 | 943,997 | 292,731 | 47,817 |
| Other Income Or Grants | ||||||||
| Cost Of Sales | 9,340,888 | 4,262,306 | 1,580,290 | 99,204 | 158,396 | 92,878 | 30,882 | |
| Gross Profit | 5,167,722 | 1,477,492 | 936,187 | 1,604,199 | 1,400,660 | 851,119 | 261,849 | 47,817 |
| Admin Expenses | 2,871,395 | 829,024 | 614,226 | 529,440 | 262,166 | 244,013 | 85,311 | 15,036 |
| Operating Profit | 2,296,327 | 648,468 | 321,961 | 1,074,759 | 1,138,494 | 607,106 | 176,538 | 32,781 |
| Interest Payable | 506 | 617,577 | 595,891 | 380,524 | 151,089 | 22,481 | ||
| Interest Receivable | ||||||||
| Pre-Tax Profit | 2,296,327 | 647,962 | 321,961 | 457,182 | 542,603 | 226,582 | 25,449 | 10,300 |
| Tax | -574,082 | -123,113 | -61,173 | -86,865 | -13,204 | -4,835 | ||
| Profit After Tax | 1,722,245 | 524,849 | 260,788 | 370,317 | 529,399 | 221,747 | 25,449 | 10,300 |
| Dividends Paid | ||||||||
| Retained Profit | 1,722,245 | 524,849 | 260,788 | 370,317 | 529,399 | 221,747 | 25,449 | 10,300 |
| Employee Costs | ||||||||
| Number Of Employees | 4 | 4 | 4 | 4 | 4 | 5 | 5 | |
| EBITDA* | 2,296,327 | 648,468 | 321,961 | 1,074,759 | 1,138,494 | 607,106 | 176,538 | 32,781 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | |
|---|---|---|---|---|---|---|---|---|
| Tangible Assets | ||||||||
| Intangible Assets | ||||||||
| Investments & Other | 2 | 2 | ||||||
| Debtors (Due After 1 year) | 6,235,000 | 3,560,000 | 10,600,000 | |||||
| Total Fixed Assets | 6,235,000 | 3,560,000 | 10,600,000 | 2 | 2 | |||
| Stock & work in progress | ||||||||
| Trade Debtors | 9,796,694 | 6,965,924 | 17,118,296 | 20,368,735 | 18,761,866 | 10,724,255 | 5,488,055 | 941,712 |
| Group Debtors | 2,302,701 | 43,301 | 2,602,527 | |||||
| Misc Debtors | 1,386,907 | 735,283 | 381,335 | 4,532 | 1,211 | |||
| Cash | 371,757 | 1,599 | 268,550 | 16,505,998 | 11,307,872 | 109 | 8,369 | |
| misc current assets | ||||||||
| total current assets | 13,858,059 | 7,746,107 | 20,370,708 | 36,874,733 | 30,069,738 | 10,728,787 | 5,489,375 | 950,081 |
| total assets | 20,093,059 | 11,306,107 | 30,970,708 | 36,874,733 | 30,069,740 | 10,728,789 | 5,489,375 | 950,081 |
| Bank overdraft | 17,719 | |||||||
| Bank loan | 12,384,168 | 7,561,943 | 5,392,193 | 2,502,713 | ||||
| Trade Creditors | 96 | 2,742 | 341 | |||||
| Group/Directors Accounts | 15,845,447 | 9,338,335 | 29,527,689 | 23,311,130 | 21,682,733 | 4,996,299 | 2,909,711 | 915,469 |
| other short term finances | ||||||||
| hp & lease commitments | ||||||||
| other current liabilities | 2,700 | 2,700 | 13,204 | 43,688 | 21,202 | 4,312 | ||
| total current liabilities | 15,845,447 | 9,341,035 | 29,530,485 | 35,695,298 | 29,260,622 | 10,450,240 | 5,433,626 | 919,781 |
| loans | ||||||||
| hp & lease commitments | ||||||||
| Accruals and Deferred Income | ||||||||
| other liabilities | ||||||||
| provisions | ||||||||
| total long term liabilities | ||||||||
| total liabilities | 15,845,447 | 9,341,035 | 29,530,485 | 35,695,298 | 29,260,622 | 10,450,240 | 5,433,626 | 919,781 |
| net assets | 4,247,612 | 1,965,072 | 1,440,223 | 1,179,435 | 809,118 | 278,549 | 55,749 | 30,300 |
| total shareholders funds | 4,247,612 | 1,965,072 | 1,440,223 | 1,179,435 | 809,118 | 278,549 | 55,749 | 30,300 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Operating Profit | 2,296,327 | 648,468 | 321,961 | 1,074,759 | 1,138,494 | 607,106 | 176,538 | 32,781 |
| Depreciation | ||||||||
| Amortisation | ||||||||
| Tax | -574,082 | -123,113 | -61,173 | -86,865 | -13,204 | -4,835 | ||
| Stock | ||||||||
| Debtors | 8,416,794 | -19,397,650 | 10,333,423 | 1,606,869 | 8,033,079 | 5,239,521 | 4,547,554 | 941,712 |
| Creditors | -96 | 96 | -2,742 | 2,401 | 341 | |||
| Accruals and Deferred Income | -2,700 | 2,700 | -13,204 | -30,484 | 22,486 | 16,890 | 4,312 | |
| Deferred Taxes & Provisions | ||||||||
| Cash flow from operations | -6,697,249 | 19,922,909 | -10,069,839 | -634,921 | -6,935,872 | -4,614,423 | -4,354,126 | -904,619 |
| Investing Activities | ||||||||
| capital expenditure | ||||||||
| Change in Investments | -2 | 2 | ||||||
| cash flow from investments | ||||||||
| Financing Activities | ||||||||
| Bank loans | -12,384,168 | 4,822,225 | 2,169,750 | 2,889,480 | 2,502,713 | |||
| Group/Directors Accounts | 6,507,112 | -20,189,354 | 6,216,559 | 1,628,397 | 16,686,434 | 2,086,588 | 1,994,242 | 915,469 |
| Other Short Term Loans | ||||||||
| Long term loans | ||||||||
| Hire Purchase and Lease Commitments | ||||||||
| other long term liabilities | ||||||||
| share issue | ||||||||
| interest | -506 | -617,577 | -595,891 | -380,524 | -151,089 | -22,481 | ||
| cash flow from financing | 7,067,407 | -20,189,860 | -6,167,609 | 5,833,045 | 18,261,463 | 4,596,597 | 4,345,866 | 912,988 |
| cash and cash equivalents | ||||||||
| cash | 370,158 | -266,951 | -16,237,448 | 5,198,126 | 11,307,872 | -109 | -8,260 | 8,369 |
| overdraft | -17,719 | 17,719 | ||||||
| change in cash | 370,158 | -266,951 | -16,237,448 | 5,198,126 | 11,325,591 | -17,828 | -8,260 | 8,369 |
rx bridge limited Credit Report and Business Information
Rx Bridge Limited Competitor Analysis
Perform a competitor analysis for rx bridge limited by selecting its closest rivals, whether from the FINANCIAL AND INSURANCE ACTIVITIES sector, other mid companies, companies in WC1B area or any other competitors across 12 key performance metrics.
rx bridge limited Ownership
RX BRIDGE LIMITED group structure
Rx Bridge Limited has no subsidiary companies.
Ultimate parent company
SCOP 1994 TRUST
#0095407
2 parents
RX BRIDGE LIMITED
09972799
rx bridge limited directors
Rx Bridge Limited currently has 5 directors. The longest serving directors include Mr Mark Coxhead (Jan 2016) and Mr Olivier Bonavero (May 2016).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Mark Coxhead | England | 56 years | Jan 2016 | - | Director |
| Mr Olivier Bonavero | 47 years | May 2016 | - | Director | |
| Mr Mark Spiteri | United Kingdom | 50 years | May 2016 | - | Director |
| Mr Sebastian Miles | United Kingdom | 41 years | May 2019 | - | Director |
| Jonathan Dickie | England | 39 years | Feb 2024 | - | Director |
P&L
March 2024turnover
14.5m
+153%
operating profit
2.3m
+254%
gross margin
35.7%
+38.37%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
4.2m
+1.16%
total assets
20.1m
+0.78%
cash
371.8k
+231.49%
net assets
Total assets minus all liabilities
rx bridge limited company details
company number
09972799
Type
Private limited with Share Capital
industry
64929 - Other credit granting (not including credit granting by non-deposit taking finance houses and other specialist consumer credit grantors and activities of mortgage finance companies) n.e.c.
incorporation date
January 2016
age
9
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
COTTONS ACCOUNTANTS LLP
address
8 bloomsbury street, london, WC1B 3SR
Bank
NATIONAL WESTMINSTER BANK PLC
Legal Advisor
-
rx bridge limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to rx bridge limited. Currently there are 0 open charges and 1 have been satisfied in the past.
rx bridge limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for RX BRIDGE LIMITED. This can take several minutes, an email will notify you when this has completed.
rx bridge limited Companies House Filings - See Documents
| date | description | view/download |
|---|
